Copyright Reports & Markets. All rights reserved.

Global Calcitonin Gene Related Peptide Type 1 Receptor Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Calcitonin Gene Related Peptide Type 1 Receptor Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size Growth Rate by Product
      • 1.4.2 AFAP-3
      • 1.4.3 AGN-241689
      • 1.4.4 CGRP
      • 1.4.5 Erenumab
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size Growth Rate by End User
      • 1.5.2 Cardiovascular
      • 1.5.3 Metabolic Disorders
      • 1.5.4 Dental Pain
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Size
      • 2.1.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue 2014-2025
      • 2.1.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales 2014-2025
    • 2.2 Calcitonin Gene Related Peptide Type 1 Receptor Growth Rate by Regions
      • 2.2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Regions
      • 2.2.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Calcitonin Gene Related Peptide Type 1 Receptor Sales by Manufacturers
      • 3.1.1 Calcitonin Gene Related Peptide Type 1 Receptor Sales by Manufacturers
      • 3.1.2 Calcitonin Gene Related Peptide Type 1 Receptor Sales Market Share by Manufacturers
      • 3.1.3 Global Calcitonin Gene Related Peptide Type 1 Receptor Market Concentration Ratio (CR5 and HHI)
    • 3.2 Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Manufacturers
      • 3.2.1 Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Manufacturers (2014-2019)
      • 3.2.2 Calcitonin Gene Related Peptide Type 1 Receptor Revenue Share by Manufacturers (2014-2019)
    • 3.3 Calcitonin Gene Related Peptide Type 1 Receptor Price by Manufacturers
    • 3.4 Calcitonin Gene Related Peptide Type 1 Receptor Manufacturing Base Distribution, Product Types
      • 3.4.1 Calcitonin Gene Related Peptide Type 1 Receptor Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Calcitonin Gene Related Peptide Type 1 Receptor Product Type
      • 3.4.3 Date of International Manufacturers Enter into Calcitonin Gene Related Peptide Type 1 Receptor Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales by Product
    • 4.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Product
    • 4.3 Calcitonin Gene Related Peptide Type 1 Receptor Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Breakdown Data by End User

    6 North America

    • 6.1 North America Calcitonin Gene Related Peptide Type 1 Receptor by Countries
      • 6.1.1 North America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Countries
      • 6.1.2 North America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Calcitonin Gene Related Peptide Type 1 Receptor by Product
    • 6.3 North America Calcitonin Gene Related Peptide Type 1 Receptor by End User

    7 Europe

    • 7.1 Europe Calcitonin Gene Related Peptide Type 1 Receptor by Countries
      • 7.1.1 Europe Calcitonin Gene Related Peptide Type 1 Receptor Sales by Countries
      • 7.1.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Calcitonin Gene Related Peptide Type 1 Receptor by Product
    • 7.3 Europe Calcitonin Gene Related Peptide Type 1 Receptor by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor by Countries
      • 8.1.1 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Sales by Countries
      • 8.1.2 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor by Product
    • 8.3 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor by End User

    9 Central & South America

    • 9.1 Central & South America Calcitonin Gene Related Peptide Type 1 Receptor by Countries
      • 9.1.1 Central & South America Calcitonin Gene Related Peptide Type 1 Receptor Sales by Countries
      • 9.1.2 Central & South America Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Calcitonin Gene Related Peptide Type 1 Receptor by Product
    • 9.3 Central & South America Calcitonin Gene Related Peptide Type 1 Receptor by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor by Countries
      • 10.1.1 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Sales by Countries
      • 10.1.2 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor by Product
    • 10.3 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor by End User

    11 Company Profiles

    • 11.1 Allergan Plc
      • 11.1.1 Allergan Plc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Allergan Plc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
      • 11.1.5 Allergan Plc Recent Development
    • 11.2 Amgen Inc
      • 11.2.1 Amgen Inc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Amgen Inc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
      • 11.2.5 Amgen Inc Recent Development
    • 11.3 Biohaven Pharmaceutical Holding Company Ltd
      • 11.3.1 Biohaven Pharmaceutical Holding Company Ltd Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Biohaven Pharmaceutical Holding Company Ltd Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
      • 11.3.5 Biohaven Pharmaceutical Holding Company Ltd Recent Development
    • 11.4 Eli Lilly and Company
      • 11.4.1 Eli Lilly and Company Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Eli Lilly and Company Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
      • 11.4.5 Eli Lilly and Company Recent Development
    • 11.5 Fortress Biotech Inc
      • 11.5.1 Fortress Biotech Inc Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Fortress Biotech Inc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
      • 11.5.5 Fortress Biotech Inc Recent Development
    • 11.6 Merck & Co Inc
      • 11.6.1 Merck & Co Inc Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Merck & Co Inc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
      • 11.6.5 Merck & Co Inc Recent Development
    • 11.7 Teva Pharmaceutical Industries Ltd
      • 11.7.1 Teva Pharmaceutical Industries Ltd Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Teva Pharmaceutical Industries Ltd Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
      • 11.7.5 Teva Pharmaceutical Industries Ltd Recent Development
    • 11.8 Vertex Pharmaceuticals Inc
      • 11.8.1 Vertex Pharmaceuticals Inc Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Vertex Pharmaceuticals Inc Calcitonin Gene Related Peptide Type 1 Receptor Products Offered
      • 11.8.5 Vertex Pharmaceuticals Inc Recent Development

    12 Future Forecast

    • 12.1 Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast by Regions
      • 12.1.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast by Regions 2019-2025
    • 12.2 Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast by Product
      • 12.2.1 Global Calcitonin Gene Related Peptide Type 1 Receptor Sales Forecast by Product 2019-2025
      • 12.2.2 Global Calcitonin Gene Related Peptide Type 1 Receptor Revenue Forecast by Product 2019-2025
    • 12.3 Calcitonin Gene Related Peptide Type 1 Receptor Market Forecast by End User
    • 12.4 North America Calcitonin Gene Related Peptide Type 1 Receptor Forecast
    • 12.5 Europe Calcitonin Gene Related Peptide Type 1 Receptor Forecast
    • 12.6 Asia Pacific Calcitonin Gene Related Peptide Type 1 Receptor Forecast
    • 12.7 Central & South America Calcitonin Gene Related Peptide Type 1 Receptor Forecast
    • 12.8 Middle East and Africa Calcitonin Gene Related Peptide Type 1 Receptor Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Calcitonin Gene Related Peptide Type 1 Receptor Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Calcitonin Gene Related Peptide Type 1 Receptor market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Calcitonin Gene Related Peptide Type 1 Receptor market based on company, product type, end user and key regions.

      This report studies the global market size of Calcitonin Gene Related Peptide Type 1 Receptor in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Calcitonin Gene Related Peptide Type 1 Receptor in these regions.
      This research report categorizes the global Calcitonin Gene Related Peptide Type 1 Receptor market by top players/brands, region, type and end user. This report also studies the global Calcitonin Gene Related Peptide Type 1 Receptor market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Allergan Plc
      Amgen Inc
      Biohaven Pharmaceutical Holding Company Ltd
      Eli Lilly and Company
      Fortress Biotech Inc
      Merck & Co Inc
      Teva Pharmaceutical Industries Ltd
      Vertex Pharmaceuticals Inc

      Market size by Product
      AFAP-3
      AGN-241689
      CGRP
      Erenumab
      Others
      Market size by End User
      Cardiovascular
      Metabolic Disorders
      Dental Pain
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Calcitonin Gene Related Peptide Type 1 Receptor market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Calcitonin Gene Related Peptide Type 1 Receptor market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Calcitonin Gene Related Peptide Type 1 Receptor companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Calcitonin Gene Related Peptide Type 1 Receptor submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Calcitonin Gene Related Peptide Type 1 Receptor are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Calcitonin Gene Related Peptide Type 1 Receptor market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now